Danaher shares jump 7% as the turnaround in biotech spending finally arrives

There was much more to like in this print, including strong headline results on the back of strength in all key operating segments.

Previous post Virgin Galactic skyrockets 21%, stock on pace for biggest gain in 10 months
Next post IBM nears acquisition of HashiCorp: report